Published in

Taylor and Francis Group, Expert Review of Endocrinology and Metabolism, p. 1-18, 2023

DOI: 10.1080/17446651.2023.2185221

Links

Tools

Export citation

Search in Google Scholar

Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO